Brief: Avidity Biosciences Announces U.S. Managed Access Program (Map) For Investigational Therapy Del-Zota In Dmd44
19/11/2025 14:15
Avidity Biosciences Inc RNA.O: AVIDITY BIOSCIENCES ANNOUNCES U.S. MANAGED ACCESS PROGRAM (MAP) FOR INVESTIGATIONAL THERAPY DEL-ZOTA IN DMD44 AVIDITY BIOSCIENCES INC - PLANS BLA SUBMISSION FOR DEL-ZOTA IN 2026 Source text: ID:nPnc78Mlha Further company coverage: RNA.O
Recent news on Avidity Biosciences
See all newsFactbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
Brief: Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off